LATE-BREAKING ABSTRACT: The heterogeneity of systemic inflammation in bronchiectasis
John R Hurst (London, United Kingdom), A. Saleh, J. Chalmers, A. de Soyza, T. Fardon, S. Koustas, J. Scott, J. Simpson, J. Brown, J. Hurst
|  |
Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome
Vincent Cottin (Lyon, France), Vincent Cottin, David M. Hansell, Nicola Sverzellati, Derek Weycker, Katerina M. Antoniou, Mark Atwood, Gerry Oster, Frank Weber, Klaus-Uwe Kirchgaessler, Harold R. Collard, Athol U. Wells
| |
Safety and tolerability of pirfenidone (PFD) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)–The LOTUSS study
Dinesh Khanna (Ann Arbor, United States of America), Dinesh Khanna, Carlo Albera, Aryeh Fischer, James Seibold, Ganesh Raghu, Nader Khalidi, Lorinda Chung, Elena Schiopu, Dan Chen, Eduard Gorina
| |
Effect of pirfenidone on treatment-emergent (TE) all-cause mortality (ACM) in patients with idiopathic pulmonary fibrosis (IPF): Pooled data analysis from ASCEND and CAPACITY
Steven Nathan (Falls Church, United States of America), Steven D. Nathan, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois, Elizabeth A. Fagan, Ian Glaspole, Marilyn K. Glassberg, David Kardatzke, Talmadge E. King Jr., Klaus-Uwe Kirchgaessler, Lisa H. Lancaster, David J. Lederer, Carlos A. Pereira, Jeffrey J. Swigris, Dominique Valeyre, Paul W. Noble
|   |
Benefit of continued pirfenidone treatment following hospitalisation within the first 6 months of therapy—Ad hoc analysis from three phase 3 trials in patients with idiopathic pulmonary fibrosis (IPF)
Steven Nathan (Falls Church, United States of America), Steven Nathan, Carlo Albera, Williamson Bradford, Ulrich Costabel, Roland Du Bois, Elizabeth Fagan, Robert Fishman, Ian Glaspole, Marilyn Glassberg, Kenneth Glasscock, Lisa Lancaster, David Lederer, Zhengning Lin, Carlos Pereira, Jeffrey Swigris, Dominique Valeyre, Paul Noble, Athol Wells
| |
Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry
Esquinas Esquinas Lopez (Lleida, Spain), Cristina Esquinas, Sonia Serreri, Miriam Barrecheguren, Beatriz Lara, Esther Rodriguez, Pietro Pirina, Ignacio Blanco, Marc Miravitlles
| |
Health-related quality of life in patients with alpha-1 antitrypsin deficiency
Ana Margarida Redondo (Porto, Portugal), Margarida Torres Redondo, Elsa Campoa, Sandra Saganha, Maria Sucena
| |
Clinical characteristics and follow up in adult patients with primary ciliary dyskinesia
Justine Frija-Masson (Paris, France), Justine Frija-Masson, Laurence Bassinet, Isabelle Honore, Nadine Desmazes-Dufeu, Bruno Housset, André Coste, Estelle Escudier, Pierre-Régis Burgel, Bernard Maître
| |